Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study
In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases...
Gespeichert in:
| Veröffentlicht in: | Tijdschrift voor psychiatrie 2007, Vol.49 (4), p.263 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | dut |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 263 |
| container_title | Tijdschrift voor psychiatrie |
| container_volume | 49 |
| creator | Neves Ramos, D van West, D van Strien, A P M |
| description | In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases for information about the recommended dose of quetiapine for children with GTS. From the 12 case-studies and one open-label trial that we found, we conclude that the maximum dose of quetiapine for children with GTS is 200 mg. Data concerning the safety of quetiapine when administered to children are limited and contradictory. |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17436213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17436213</sourcerecordid><originalsourceid>FETCH-LOGICAL-p543-674cfd085808813ecd114784dd6b31445e44b803ccd47cf717287767886d2e6a3</originalsourceid><addsrcrecordid>eNo1j8tqwzAQAHVoadI0v1D0Ay6Sd61VjiG0aSEQAr4HWVoTF7-w5IP_vqWP08AcBuZOrBUoyAhgtxKPMX4qhWYH9CBWmhBMrmEtzpeZU-PGpmfZ9DLdWKaJXeq4T3Kof8SxaVuOMrBsnSyHeeKUWMalD9PQ8YvcS-_it0hzWJ7Efe3ayNs_bkT59loe3rPT-fhx2J-ysUDIDKGvg7KFVdZqYB-0RrIYgqlAIxaMWFkF3gckX5Om3BIZstaEnI2DjXj-zY5z1XG4jlPTuWm5_o_BF0TYR6c</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Neves Ramos, D ; van West, D ; van Strien, A P M</creator><creatorcontrib>Neves Ramos, D ; van West, D ; van Strien, A P M</creatorcontrib><description>In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases for information about the recommended dose of quetiapine for children with GTS. From the 12 case-studies and one open-label trial that we found, we conclude that the maximum dose of quetiapine for children with GTS is 200 mg. Data concerning the safety of quetiapine when administered to children are limited and contradictory.</description><identifier>ISSN: 0303-7339</identifier><identifier>PMID: 17436213</identifier><language>dut</language><publisher>Netherlands</publisher><subject>Antipsychotic Agents - adverse effects ; Antipsychotic Agents - therapeutic use ; Child ; Dibenzothiazepines - adverse effects ; Dibenzothiazepines - therapeutic use ; Humans ; Male ; Quetiapine Fumarate ; Safety ; Tourette Syndrome - drug therapy ; Treatment Outcome</subject><ispartof>Tijdschrift voor psychiatrie, 2007, Vol.49 (4), p.263</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17436213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neves Ramos, D</creatorcontrib><creatorcontrib>van West, D</creatorcontrib><creatorcontrib>van Strien, A P M</creatorcontrib><title>Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study</title><title>Tijdschrift voor psychiatrie</title><addtitle>Tijdschr Psychiatr</addtitle><description>In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases for information about the recommended dose of quetiapine for children with GTS. From the 12 case-studies and one open-label trial that we found, we conclude that the maximum dose of quetiapine for children with GTS is 200 mg. Data concerning the safety of quetiapine when administered to children are limited and contradictory.</description><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Child</subject><subject>Dibenzothiazepines - adverse effects</subject><subject>Dibenzothiazepines - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Quetiapine Fumarate</subject><subject>Safety</subject><subject>Tourette Syndrome - drug therapy</subject><subject>Treatment Outcome</subject><issn>0303-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tqwzAQAHVoadI0v1D0Ay6Sd61VjiG0aSEQAr4HWVoTF7-w5IP_vqWP08AcBuZOrBUoyAhgtxKPMX4qhWYH9CBWmhBMrmEtzpeZU-PGpmfZ9DLdWKaJXeq4T3Kof8SxaVuOMrBsnSyHeeKUWMalD9PQ8YvcS-_it0hzWJ7Efe3ayNs_bkT59loe3rPT-fhx2J-ysUDIDKGvg7KFVdZqYB-0RrIYgqlAIxaMWFkF3gckX5Om3BIZstaEnI2DjXj-zY5z1XG4jlPTuWm5_o_BF0TYR6c</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>Neves Ramos, D</creator><creator>van West, D</creator><creator>van Strien, A P M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>2007</creationdate><title>Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study</title><author>Neves Ramos, D ; van West, D ; van Strien, A P M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p543-674cfd085808813ecd114784dd6b31445e44b803ccd47cf717287767886d2e6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>dut</language><creationdate>2007</creationdate><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Child</topic><topic>Dibenzothiazepines - adverse effects</topic><topic>Dibenzothiazepines - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Quetiapine Fumarate</topic><topic>Safety</topic><topic>Tourette Syndrome - drug therapy</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Neves Ramos, D</creatorcontrib><creatorcontrib>van West, D</creatorcontrib><creatorcontrib>van Strien, A P M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Tijdschrift voor psychiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neves Ramos, D</au><au>van West, D</au><au>van Strien, A P M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study</atitle><jtitle>Tijdschrift voor psychiatrie</jtitle><addtitle>Tijdschr Psychiatr</addtitle><date>2007</date><risdate>2007</risdate><volume>49</volume><issue>4</issue><spage>263</spage><pages>263-</pages><issn>0303-7339</issn><abstract>In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases for information about the recommended dose of quetiapine for children with GTS. From the 12 case-studies and one open-label trial that we found, we conclude that the maximum dose of quetiapine for children with GTS is 200 mg. Data concerning the safety of quetiapine when administered to children are limited and contradictory.</abstract><cop>Netherlands</cop><pmid>17436213</pmid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0303-7339 |
| ispartof | Tijdschrift voor psychiatrie, 2007, Vol.49 (4), p.263 |
| issn | 0303-7339 |
| language | dut |
| recordid | cdi_pubmed_primary_17436213 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Child Dibenzothiazepines - adverse effects Dibenzothiazepines - therapeutic use Humans Male Quetiapine Fumarate Safety Tourette Syndrome - drug therapy Treatment Outcome |
| title | Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A43%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quetiapine%20in%20the%20treatment%20of%20the%20Gilles%20de%20la%20Tourette%20syndrome.%20A%20case%20study&rft.jtitle=Tijdschrift%20voor%20psychiatrie&rft.au=Neves%20Ramos,%20D&rft.date=2007&rft.volume=49&rft.issue=4&rft.spage=263&rft.pages=263-&rft.issn=0303-7339&rft_id=info:doi/&rft_dat=%3Cpubmed%3E17436213%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17436213&rfr_iscdi=true |